Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 4/20 | 0.42 |
| ▸ | OPRK1 known ✓ | P41145 | 4/20 | 0.42 |
| ▸ | OPRD1 known ✓ | P41143 | 1/20 | 0.42 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.41 |
| ▸ | HSD11B1 known ✓ | P28845 | 1/20 | 0.40 |
| ▸ | HTR2C known ✓ | P28335 | 2/20 | 0.37 |
| ▸ | HTR2B known ✓ | P41595 | 2/20 | 0.37 |
| ▸ | OGFRL1 | Q5TC84 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28132082 | 1.00 | OPRM1 (0.42) | OPRM1OPRK1OPRD1OGFRL1MEN1 | |
| SCHEMBL1043568 | 0.98 | OPRM1 (0.43) | OPRM1OPRK1OPRD1OGFRL1MEN1 | |
| SCHEMBL4934890 | 0.72 | HTR2C (0.58) | OPRM1OPRK1OPRD1MEN1KMT2A | |
| SCHEMBL30673810 | 0.71 | OPRM1 (0.41) | OPRM1OPRK1OPRD1OGFRL1MEN1 | |
| SCHEMBL27971621 | 0.71 | SLC18A3 (0.41) | OPRM1OPRK1OPRD1OGFRL1MEN1 | |
| SCHEMBL180964 | 0.71 | BCHE (0.41) | OPRM1OPRK1OPRD1OGFRL1MEN1 | |
| SCHEMBL30600476 | 0.71 | BCHE (0.41) | OPRM1OPRK1OPRD1OGFRL1MEN1 | |
| SCHEMBL21307175 | 0.71 | HTR2C (0.60) | OPRM1OPRK1OPRD1MEN1KMT2A | |
| SCHEMBL21307179 | 0.71 | HTR2C (0.60) | OPRM1OPRK1OPRD1MEN1KMT2A | |
| SCHEMBL29091543 | 0.71 | GAA (0.58) | OPRM1OPRK1OPRD1OGFRL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117069770-A | Method for synthesizing N-heterocyclic carbene complex by utilizing hydrogen bond | 石河子大学 | 2023-11-17 | — | — | CN | claimed |
| CN-117069770-A | Method for synthesizing N-heterocyclic carbene complex by utilizing hydrogen bond | 石河子大学 | 2023-11-17 | — | — | CN | disclosed |
| US-20190177265-A1 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | DOW AGROSCIENCES LLC (US) | 2019-06-13 | — | — | US | disclosed |
| US-20190077744-A1 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | DOW AGROSCIENCES LLC | 2019-03-14 | — | — | US | disclosed |
| EP-3429987-A1 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | Dow Global Technologies LLC (US) | 2019-01-23 | — | — | EP | disclosed |
| US-10125082-B2 | Method for coupling a first compound to a second compound | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-11-13 | — | — | US | disclosed |
| US-20180237459-A1 | METHOD FOR COUPLING AN AROMATIC OR VINYLIC COMPOUND TO A BORON-CONTAINING COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-08-23 | — | — | US | disclosed |
| US-20180237363-A1 | METHOD FOR COUPLING AN AROMATIC COMPOUND TO AN ALKYNE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-08-23 | — | — | US | disclosed |
| EP-3337808-A1 | METHOD FOR COUPLING AN AROMATIC OR VINYLIC COMPOUND TO A BORON-CONTAINING COMPOUND | Dow Global Technologies LLC (US) | 2018-06-27 | — | — | EP | disclosed |
| EP-3337783-A1 | METHOD FOR COUPLING AN AROMATIC COMPOUND TO AN ALKYNE | Dow Global Technologies LLC (US) | 2018-06-27 | — | — | EP | disclosed |
| WO-2016057770-A1 | METHOD FOR COUPLING A FLUOROSULFONATE COMPOUND WITH AN AMINE COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-04-14 | — | — | WO | disclosed |
| WO-2016057771-A1 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-04-14 | — | — | WO | disclosed |
| US-20160000757-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-07 | — | — | US | disclosed |
| WO-2015148931-A1 | METHOD FOR COUPLING A FIRST AROMATIC COMPOUND TO A SECOND AROMATIC COMPOUND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-10-01 | — | — | WO | disclosed |
| US-9072729-B2 | Method for treating fibrosis and cancer with imidazolium and imidazolinium compounds | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-07 | — | — | US | disclosed |
| EP-2803356-A1 | Method for treating neurological disorders with imidazolium and imidazolinium compounds | Agency for Science, Technology and Research (SG) | 2014-11-19 | — | — | EP | disclosed |
| US-20110178040-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-07-21 | — | — | US | disclosed |
| US-20110028513-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-02-03 | — | — | US | disclosed |
| EP-2271338-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | Agency for Science, Technology And Research (SG) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009123569-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180237459-A1 | METHOD FOR COUPLING AN AROMATIC OR VINYLIC COMPOUND TO A BORON-CONTAINING COMPOUND | PAH, BCL6, BLVRB | OPRM1 4276/4885OPRK1 3577/4885OPRD1 4051/4885 |
| US-20110028513-A1 | METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | SMN1; SMN2, INA, NLN | OPRM1 3394/4885OPRK1 2040/4885OPRD1 3439/4885 |
| US-20110178040-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | MMP1, MYLK, MMP8 | OPRM1 4432/4885OPRK1 4177/4885OPRD1 4782/4885 |
| US-20190077744-A1 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | CA6, CA2, NUDT21 | OPRM1 4503/4885OPRK1 4573/4885OPRD1 4828/4885 |
| US-20180237363-A1 | METHOD FOR COUPLING AN AROMATIC COMPOUND TO AN ALKYNE | ALK, TYR, AHR | OPRM1 3400/4885OPRK1 2354/4885OPRD1 3419/4885 |
| US-20190177265-A1 | METHOD FOR COUPLING A FIRST COMPOUND TO A SECOND COMPOUND | PAICS, NUDT21, TIAL1 | OPRM1 3583/4885OPRK1 3543/4885OPRD1 4616/4885 |
| US-10125082-B2 | Method for coupling a first compound to a second compound | SQLE, FDPS, PAICS | OPRM1 3612/4885OPRK1 3494/4885OPRD1 4482/4885 |
| US-20160000757-A1 | METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS | MMP1, MYLK, MMP8 | OPRM1 4432/4885OPRK1 4177/4885OPRD1 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.